Salud financiera de hoja de balance de Pharma Mar
Salud financiera controles de criterios 4/6
Pharma Mar tiene un patrimonio de los accionistas total de €193.4M y una deuda total de €39.9M, lo que sitúa su ratio deuda-patrimonio en 20.6%. Sus activos y pasivos totales son €340.5M y €147.1M respectivamente.
Información clave
20.6%
Ratio deuda-patrimonio
€39.86m
Deuda
| Ratio de cobertura de intereses | n/a |
| Efectivo | €162.56m |
| Patrimonio | €193.44m |
| Total pasivo | €147.08m |
| Activos totales | €340.52m |
Actualizaciones recientes sobre salud financiera
Here's Why Pharma Mar (BME:PHM) Has A Meaningful Debt Burden
Jan 25
Pharma Mar (BME:PHM) Has A Rock Solid Balance Sheet
Feb 09We Think Pharma Mar (BME:PHM) Can Manage Its Debt With Ease
Oct 27Does Pharma Mar (BME:PHM) Have A Healthy Balance Sheet?
Jul 15Pharma Mar (BME:PHM) Has A Pretty Healthy Balance Sheet
Apr 11Is Pharma Mar (BME:PHM) Using Too Much Debt?
Jan 09Recent updates
Pharma Mar, S.A. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Mar 03Here's Why Pharma Mar (BME:PHM) Has A Meaningful Debt Burden
Jan 25Pharma Mar, S.A. (BME:PHM) Shares Could Be 30% Below Their Intrinsic Value Estimate
Apr 28We Believe That Pharma Mar's (BME:PHM) Weak Earnings Are A Good Indicator Of Underlying Profitability
Mar 08Analyst Forecasts Just Became More Bearish On Pharma Mar, S.A. (BME:PHM)
Mar 05Pharma Mar (BME:PHM) Has A Rock Solid Balance Sheet
Feb 09We Think Pharma Mar (BME:PHM) Can Manage Its Debt With Ease
Oct 27An Intrinsic Calculation For Pharma Mar, S.A. (BME:PHM) Suggests It's 21% Undervalued
Sep 27Does Pharma Mar (BME:PHM) Have A Healthy Balance Sheet?
Jul 15Growth Investors: Industry Analysts Just Upgraded Their Pharma Mar, S.A. (BME:PHM) Revenue Forecasts By 24%
May 04Pharma Mar (BME:PHM) Has A Pretty Healthy Balance Sheet
Apr 11There Is A Reason Pharma Mar, S.A.'s (BME:PHM) Price Is Undemanding
Mar 16Is Pharma Mar (BME:PHM) Using Too Much Debt?
Jan 09Pharma Mar (BME:PHM) Seems To Use Debt Quite Sensibly
Sep 08News Flash: Analysts Just Made A Meaningful Upgrade To Their Pharma Mar, S.A. (BME:PHM) Forecasts
Aug 03Here's Why I Think Pharma Mar (BME:PHM) Is An Interesting Stock
May 31Pharma Mar (BME:PHM) Has A Rock Solid Balance Sheet
May 10Is Pharma Mar, S.A. (BME:PHM) Expensive For A Reason? A Look At Its Intrinsic Value
Apr 08Announcing: Pharma Mar (BME:PHM) Stock Increased An Energizing 231% In The Last Five Years
Jan 14Is Pharma Mar (BME:PHM) A Risky Investment?
Nov 19Análisis de la situación financiera
Pasivos a corto plazo: Los activos a corto plazo (€252.6M) de PHM superan a sus pasivos a corto plazo (€95.9M).
Pasivo a largo plazo: Los activos a corto plazo de PHM (€252.6M) superan a sus pasivos a largo plazo (€51.2M).
Historial y análisis de deuda-patrimonio
Nivel de deuda: PHM tiene más efectivo que su deuda total.
Reducción de la deuda: El ratio deuda-patrimonio de PHM ha pasado de 534.6% a 20.6% en los últimos 5 años.
Cobertura de la deuda: El flujo de caja operativo de PHM es negativo, por lo que la deuda no está bien cubierta.
Cobertura de intereses: Datos insuficientes para determinar si los pagos de intereses de PHM sobre su deuda están bien cubiertos por el EBIT.